Dexelvucitabine | Reverset | Reverse Transcriptase Inhibitor

首页 / 抑制剂/激动剂 / 抗感染 / NNRTI / Dexelvucitabine

Dexelvucitabine {[allProObj[0].p_purity_real_show]}

货号：A728211 同义名： Reverset;d-d4FC

Dexelvucitabine is a nucleoside reverse transcriptase inhibitor potentially for the treatment of HIV infection.

Dexelvucitabine 化学结构
CAS号：134379-77-4

Dexelvucitabine 3D分子结构
CAS号：134379-77-4

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Dexelvucitabine 纯度/质量文件产品仅供科研

货号：A728211 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

Dexelvucitabine 生物活性

描述	Dexelvucitabine is a nucleoside reverse transcriptase inhibitor potentially for the treatment of HIV infection.

Dexelvucitabine 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00040157	HIV Infections	Phase 2	Terminated(Safety concerns)	-	United States, Arizona ... 展开 >> Body Positive, Inc. Phoenix, Arizona, United States, 85006 United States, California L.a., California, United States Pacific Horizon Medical Group, Inc. San Francisco, California, United States, 94115 United States, Florida Community Health Care Center One, Inc. Ft. Lauderdale, Florida, United States, 33306 South Shore Hospital Miami Beach, Florida, United States, 33160 United States, Georgia AIDS Research Consortium Atlanta, Georgia, United States, 30308 United States, Illinois Chicago, Illinois, United States United States, New York St. Lukes Roosevelt Hospital New York, New York, United States, 10019 Stony Brook University Infectious Disease, Dept. of Medicine Stony Brook, New York, United States, 11794-8153 United States, Texas Houston, Texas, United States, 77098 Houston, Texas, United States United States, Virginia Hampton Road Medical Specialists Hampton, Virginia, United States, 23666 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98122 收起 <<
NCT00037622	Chronic Hepatitis B	Not Applicable	Terminated(Safety concerns fro... 展开 >>m other studies.) 收起 <<	-	-
NCT00034359	Hepatitis B, Chronic	Phase 2	Completed	-	Bulgaria ... 展开 >> Clinic of Gastroenterology Sofia, Bulgaria Foundation of Gastroenterology Sofia, Bulgaria Former Yugoslavia Clinic Center of Serbia, Institute of Infectious Disease Belgrade, Former Yugoslavia Clinic of Novi Sad Novi Sad, Former Yugoslavia 收起 <<

Dexelvucitabine 参考文献

[1]Meusinger R. Doubling spectroscopy challenge. Anal Bioanal Chem. 2015 Nov;407(27):8169-72.

[2]Schinazi RF, Massud I, et al. Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase. Antimicrob Agents Chemother. 2011 May;55(5):2054-60.

Dexelvucitabine 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

4.40mL

0.88mL

0.44mL

22.01mL

4.40mL

2.20mL

44.02mL

8.80mL

4.40mL

Dexelvucitabine 技术信息

CAS号	134379-77-4
分子式	C₉H₁₀FN₃O₃
分子量	227.192

别名	Reverset;d-d4FC;DOC-817. trade name: Reverset.;YZ-817;PSI-5582;INCB-8721;RVT;DPC-817;DFC;beta-D-D-4FC
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,2-8°C

溶解度

DMSO: 50 mg/mL(220.08 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00040157	HIV Infections	Phase 2	Terminated(Safety concerns)	-	United States, Arizona ... 展开 >> Body Positive, Inc. Phoenix, Arizona, United States, 85006 United States, California L.a., California, United States Pacific Horizon Medical Group, Inc. San Francisco, California, United States, 94115 United States, Florida Community Health Care Center One, Inc. Ft. Lauderdale, Florida, United States, 33306 South Shore Hospital Miami Beach, Florida, United States, 33160 United States, Georgia AIDS Research Consortium Atlanta, Georgia, United States, 30308 United States, Illinois Chicago, Illinois, United States United States, New York St. Lukes Roosevelt Hospital New York, New York, United States, 10019 Stony Brook University Infectious Disease, Dept. of Medicine Stony Brook, New York, United States, 11794-8153 United States, Texas Houston, Texas, United States, 77098 Houston, Texas, United States United States, Virginia Hampton Road Medical Specialists Hampton, Virginia, United States, 23666 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98122 收起 <<
NCT00037622	Chronic Hepatitis B	Not Applicable	Terminated(Safety concerns fro... 展开 >>m other studies.) 收起 <<	-	-
NCT00034359	Hepatitis B, Chronic	Phase 2	Completed	-	Bulgaria ... 展开 >> Clinic of Gastroenterology Sofia, Bulgaria Foundation of Gastroenterology Sofia, Bulgaria Former Yugoslavia Clinic Center of Serbia, Institute of Infectious Disease Belgrade, Former Yugoslavia Clinic of Novi Sad Novi Sad, Former Yugoslavia 收起 <<
NCT00405249	HIV Infections	Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT00040144	Chronic Hepatitis B	Phase 2	Terminated(Safety concerns)	-	United States, California ... 展开 >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 University of California-Irvine Orange, California, United States, 92868 Huntington Memorial Hospital Pasadena, California, United States, 91105 University of California-San Francisco San Francisco, California, United States, 94143-0538 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Illinois University of Illinois at Chicago Chicago, Illinois, United States, 60612-7323 University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Cornell Weill Medical College New York, New York, United States, 10021 United States, Texas Baylor Universtiy Medical Center Dallas, Texas, United States, 75246 Southwest Infectious Disease Associates, P.A. Dallas, Texas, United States, 75246 The University of Texas Dallas, Texas, United States, 75390 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 United States, Washington Unviversity of Washington Seattle, Washington, United States, 98195 Canada, British Columbia Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z 1L5 Canada, Ontario Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec University of Montreal Montreal, Quebec, Canada, H2X 3J4 China The University of Hong Kong Hong Kong SAR, China 收起 <<
NCT00040274	HIV Infections	Phase 1	Completed	-	United States, North Carolina ... 展开 >> University of North Carolina Hospitals Chapel Hill, North Carolina, United States, 27514 Germany 3ClincalResearch Center Berlin, Germany 收起 <<
NCT00380159	HIV-1 Infection	Phase 2	Completed	-	United States, Georgia ... 展开 >> ARCA Atlanta, Georgia, United States, 30308 United States, Ohio ACTU University of Cincinnati Cincinnati, Ohio, United States, 45242 Dominican Republic Dr. Salvador B Gautier Hospital Santo Domindo, Dominican Republic Germany EPIMED Berlin, Germany immunologische Ambulanz, University Clinic Bonn, Germany Klinikum der Universitat zu Koln Koln, Germany Spain Hospital La Paz Madrid, Spain 收起 <<
NCT00350272	HIV Infections	Phase 2	Completed	-	-
NCT00675844	HIV Infections	Phase 2	Completed	-	United States, Florida ... 展开 >> Orlando Immunology Center Orlando, Florida, United States, 32803 Center for the Prevention and Treatment of Infections Pensacola, Florida, United States, 32504 United States, New Jersey St Michael's Medical Center Newark, New Jersey, United States, 07102 United States, Texas Central Texas Clinical Research Austin, Texas, United States, 78705 Nicholaos Bellos, MD Dallas, Texas, United States, 75204 收起 <<
NCT00300573	HIV Infections ... 展开 >> Human Immunodeficiency Virus 收起 <<	Phase 2	Terminated(Development program... 展开 >> ended due to inability to pair with other cytidine analogs and higher risk of hyperlipasemia when not used with 3TC/FTC.) 收起 <<	-	United States, California ... 展开 >> Long Beach, California, United States, 90813 United States, Florida Brandon, Florida, United States Fort Lauderdale, Florida, United States Miami, Florida, United States Plantation, Florida, United States, 33317 United States, Georgia Atlanta, Georgia, United States, 30309 United States, Illinois Chicago, Illinois, United States, 60657 United States, New York New York, New York, United States, 10018 United States, Oregon Portland, Oregon, United States, 97209 United States, Texas Dallas, Texas, United States Puerto Rico San Juan, Puerto Rico, 00909 收起 <<
NCT00350272	-		Completed	-	-
NCT00312039	HIV Infections	Phase 1 Phase 2	Completed	-	United States, Alabama ... 展开 >> UAB Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California at Davis Sacramento, California, United States, 95817 United States, Florida University of Miami School of Medicine Miami, Florida, United States, 33136 Orlando Immunology Center Orlando, Florida, United States, 32803 Olayemi Osiyemi West Palm Beach, Florida, United States, 33401 United States, Georgia ACRA Atlanta, Georgia, United States, 30308 United States, New York Beth Israel Medical Center New York, New York, United States, 10003 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45242 收起 <<

Dexelvucitabine {[allProObj[0].p_purity_real_show]}

Dexelvucitabine 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Dexelvucitabine 质控信息

Dexelvucitabine 生物活性

Dexelvucitabine 临床研究

Dexelvucitabine 参考文献

Dexelvucitabine 实验方案

Dexelvucitabine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Dexelvucitabine {[allProObj[0].p_purity_real_show]}

Dexelvucitabine 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Dexelvucitabine 质控信息

Dexelvucitabine 生物活性

Dexelvucitabine 临床研究

Dexelvucitabine 参考文献

Dexelvucitabine 实验方案

Dexelvucitabine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Dexelvucitabine 纯度/质量文件产品仅供科研